A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Public ClinicalTrials.gov record NCT05620836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Povorcitinib (INCB054707) in participants with moderate to severe Hidradenitis Suppurativa (HS) over a 12-week placebo-controlled period, followed by a 42-week extension period.
Study identification
- NCT ID
- NCT05620836
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 619 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2023
- Primary completion
- Jan 6, 2025
- Completion
- Nov 20, 2025
- Last update posted
- Jan 8, 2026
2023 – 2025
United States locations
- U.S. sites
- 38
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site US240 | Scottsdale | Arizona | 85255 | — |
| Investigative Site US237 | Scottsdale | Arizona | 85259 | — |
| Investigative Site US214 | Arkansas City | Arkansas | 72758 | — |
| Investigative Site US242 | Fayetteville | Arkansas | 72703 | — |
| Investigative Site US223 | Los Angeles | California | 90033 | — |
| Investigative Site US226 | San Diego | California | 92103 | — |
| Investigative Site US222 | San Francisco | California | 94118 | — |
| Investigative Site US233 | Washington D.C. | District of Columbia | 20060 | — |
| Investigative Site US228 | Brandon | Florida | 33511 | — |
| Investigative Site US227 | Margate | Florida | 33063 | — |
| Investigative Site US204 | Miami | Florida | 33125 | — |
| Investigative Site US236 | Miami | Florida | 33173 | — |
| Investigative Site US200 | Ocala | Florida | 34470 | — |
| Investigative Site US201 | Tampa | Florida | 33613 | — |
| Investigative Site US220 | West Dundee | Illinois | 60118 | — |
| Investigative Site US206 | Indianapolis | Indiana | 46250 | — |
| Investigative Site US241 | Iowa City | Iowa | 52242 | — |
| Investigative Site US209 | Louisville | Kentucky | 40241 | — |
| Investigative Site US207 | Metairie | Louisiana | 70006 | — |
| Investigative Site US229 | New Orleans | Louisiana | 70115 | — |
| Investigative Site US224 | Baltimore | Maryland | 21224 | — |
| Investigative Site US208 | Beverly | Massachusetts | 01915 | — |
| Investigative Site US221 | Quincy | Massachusetts | 02169 | — |
| Investigative Site US213 | Detroit | Michigan | 48084 | — |
| Investigative Site US217 | Waterford | Michigan | 48328 | — |
| Investigative Site US212 | Minneapolis | Minnesota | 55455 | — |
| Investigative Site US239 | Omaha | Nebraska | 68144 | — |
| Investigative Site US230 | Hightstown | New Jersey | 08520 | — |
| Investigative Site US202 | New York | New York | 10003 | — |
| Investigative Site US210 | Rochester | New York | 14642 | — |
| Investigative Site US205 | Chapel Hill | North Carolina | 27516 | — |
| Investigative Site US215 | Bexley | Ohio | 43209 | — |
| Investigative Site US203 | Columbus | Ohio | 43210 | — |
| Investigative Site US232 | Murfreesboro | Tennessee | 37130 | — |
| Investigative Site US235 | Arlington | Texas | 76011 | — |
| Investigative Site US218 | Bellaire | Texas | 77401 | — |
| Investigative Site US238 | Pflugerville | Texas | 78660 | — |
| Investigative Site US234 | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05620836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05620836 live on ClinicalTrials.gov.